Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study

Acquired Haemophilia Clinical Trial

Official title:
Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study

Status Completed

Clinical Trial Summary

the aims of SACHA study was to appreciate prevalence, evolution and follow-up, treatment response of patients with acquired hemophilia with biological and clinical data. Inclusion criteria were factor VIIIc below 30% associated with presence of Facgteur VIII inhibitor (titer > 1 u Bethesda. Clinical and biologival data were obtained at Day 0 (as soon as possible and at 1, 3, 6 and 12 months.Informations were notified to co-investigators with the help of two french medical society (Internal medicine, french haemostasis and thrombosis society.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00213473
Study type	Observational
Source	University Hospital, Rouen
Contact
Status	Completed
Phase	N/A
Start date	June 2001
Completion date	May 2006

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT01403740` - Turkish Acquired Haemophilia Registry	N/A
Recruiting	`NCT01808911` - Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)	Phase 3
Completed	`NCT00697320` - Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany	N/A
Completed	`NCT01285089` - Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia	N/A
Completed	`NCT01561417` - Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects	Phase 1